Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

AIM: Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the possible in...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Neuropsychopharmacol Rep
Κύριοι συγγραφείς: Kudo, Noriko, Yamamori, Hidenaga, Ishima, Tamaki, Nemoto, Kiyotaka, Yasuda, Yuka, Fujimoto, Michiko, Azechi, Hirotsugu, Niitsu, Tomihisa, Numata, Shusuke, Ikeda, Manabu, Iyo, Masaomi, Ohmori, Tetsuro, Fukunaga, Masaki, Watanabe, Yoshiyuki, Hashimoto, Kenji, Hashimoto, Ryota
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Original Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7722656/
https://ncbi.nlm.nih.gov/pubmed/32022478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12098
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια